Rasistion- and obasky-associated metabolic diseases

被引：149

作者：

Lazar, M. A. ^{[1
]}

机构：

[1] Hosp Univ Penn, Sch Med, Inst Diabet Obes & Metab, Dept Med,Div Endocrinol Diabet & Metab, Philadelphia, PA 19104 USA

来源：

HORMONE AND METABOLIC RESEARCH | 2007年 / 39卷 / 10期

关键词：

obesity; insulin resistance; resistin; adipokine;

D O I：

10.1055/s-2007-985897

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

The link between obesity and diabetes is strong as well as complex. Fat cells produce many circulating regulators of insulin sensitivity, including pro-inflammatory cytokines. In rodents, resistin is produced by adipose tissue, and is a significant regulator of glucose metabolism and insulin sensitivity. In humans, resistin is derived made mainly from macrophages. Given the emerging interrelationship between inflammation and metabolic disease, hyperresistinemia may be a biomarker, and/or a mediator, of metabolic and inflammatory diseases in humans as well as in rodents.

引用

收藏

页码：710 / 716

页数：7

相关论文

共 127 条

[81] Regulation of resistin expression and circulating levels in obesity, diabetes, and fasting [J].

Rajala, MW ;

Qi, Y ;

Patel, HR ;

Takahashi, N ;

Banerjee, R ;

Pajvani, UB ;

Sinha, MK ;

Gingerich, RL ;

Scherer, PE ;

Ahima, RS .

DIABETES, 2004, 53 (07) :1671-1679

[82] Adipose-derived resistin and gut-derived resistin-like molecule-β selectively impair insulin action on glucose production [J].

Rajala, MW ;

Obici, S ;

Scherer, PE ;

Rossetti, L .

JOURNAL OF CLINICAL INVESTIGATION, 2003, 111 (02) :225-230

[83] Abnormal glucose homeostasis due to chronic hyperresistinemia [J].

Rangwala, SM ;

Rich, AS ;

Rhoades, B ;

Shapiro, JS ;

Obici, S ;

Rossetti, L ;

Lazar, MA .

DIABETES, 2004, 53 (08) :1937-1941

[84] Peroxisome proliferator-activated receptor γ in diabetes and metabolism [J].

Rangwala, SM ;

Lazar, MA .

TRENDS IN PHARMACOLOGICAL SCIENCES, 2004, 25 (06) :331-336

[85] Resistin is an inflammatory marker of atherosclerosis in humans [J].

Reilly, MP ;

Lehrke, M ;

Wolfe, ML ;

Rohatgi, A ;

Lazar, MA ;

Rader, DJ .

CIRCULATION, 2005, 111 (07) :932-939

[86] The peroxisome proliferator-activated receptor-γ is a negative regulator of macrophage activation [J].

Ricote, M ;

Li, AC ;

Willson, TM ;

Kelly, CJ ;

Glass, CK .

NATURE, 1998, 391 (6662) :79-82

[87] SOCS-1 and SOCS-3 block insulin signaling by ubiquitin-mediated degradation of IRS1 and IRS2 [J].

Rui, LY ;

Yuan, MS ;

Frantz, D ;

Shoelson, S ;

White, MF .

JOURNAL OF BIOLOGICAL CHEMISTRY, 2002, 277 (44) :42394-42398

[88] CLONING AND CHARACTERIZATION OF THE CDNA-ENCODING A NOVEL HUMAN PRE-B-CELL COLONY-ENHANCING FACTOR [J].

SAMAL, B ;

SUN, YH ;

STEARNS, G ;

XIE, CS ;

SUGGS, S ;

MCNIECE, I .

MOLECULAR AND CELLULAR BIOLOGY, 1994, 14 (02) :1431-1437

[89] Adenovirus-mediated chronic "hyper-resistinemia" leads to in vivo insulin resistance in normal rats [J].

Satoh, H ;

Nguyen, MTA ;

Miles, PDG ;

Imamura, T ;

Usui, I ;

Olefsky, JM .

JOURNAL OF CLINICAL INVESTIGATION, 2004, 114 (02) :224-231

[90] Resistin/Fizz3 expression in relation to obesity and peroxisome proliferator-activated receptor-γ action in humans [J].

Savage, DB ;

Sewter, CP ;

Klenk, ES ;

Segal, DG ;

Vidal-Puig, A ;

Considine, RV ;

O'Rahilly, S .

DIABETES, 2001, 50 (10) :2199-2202

← 4 5 6 7 8 9 10 11 12 13 →